160 related articles for article (PubMed ID: 19276301)
1. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus.
Robak E; Kierstan M; Cebula B; Krawczynska A; Sysa-Jedrzejowska A; Wierzbowska A; Smolewski P; Robak T
Lupus; 2009 Apr; 18(4):332-41. PubMed ID: 19276301
[TBL] [Abstract][Full Text] [Related]
2. Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus.
Robak E; Kulczycka L; Sysa-Jedrzejowska A; Wierzbowska A; Robak T
Eur Cytokine Netw; 2007 Dec; 18(4):181-7. PubMed ID: 17964973
[TBL] [Abstract][Full Text] [Related]
3. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
5. Investigating the role of angiogenesis in systemic lupus erythematosus.
Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
[TBL] [Abstract][Full Text] [Related]
6. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
[TBL] [Abstract][Full Text] [Related]
7. Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients.
Robak E; Kulczycka-Siennicka L; Gerlicz Z; Kierstan M; Korycka-Wolowiec A; Sysa-Jedrzejowska A
Eur Cytokine Netw; 2013 Mar; 24(1):60-8. PubMed ID: 23661335
[TBL] [Abstract][Full Text] [Related]
8. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients.
Wierzbowska A; Robak T; Krawczyńska A; Pluta A; Wrzesień-Kuś A; Cebula B; Robak E; Smolewski P
Ann Hematol; 2008 Feb; 87(2):97-106. PubMed ID: 17849117
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
Robak E; Sysa-Jedrzejewska A; Robak T
Mediators Inflamm; 2003 Oct; 12(5):293-8. PubMed ID: 14760936
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic activity in sera of patients with systemic lupus erythematosus.
Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M
Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266
[TBL] [Abstract][Full Text] [Related]
12. Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results.
Vizio B; Novarino A; Giacobino A; Cristiano C; Prati A; Brondino G; Ciuffreda L; Bellone G
Cancer Sci; 2010 Nov; 101(11):2448-54. PubMed ID: 20950371
[TBL] [Abstract][Full Text] [Related]
13. [Circulating endothelial cells, endothelial precursors, VEGF and bFGF concentrations in patients with acute leukemias, lymphomas and myelomas].
Poreba M; Jaźwiec B; Kuliczkowski K; Poreba R
Pol Arch Med Wewn; 2005 Jan; 113(1):27-34. PubMed ID: 16130598
[TBL] [Abstract][Full Text] [Related]
14. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
[TBL] [Abstract][Full Text] [Related]
15. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
Cieślik P; Hrycek A
Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of soluble-endoglin levels in systemic lupus erythematosus: possible association with anti-phospholipid syndrome.
Bassyouni IH; El-Shazly R; Azkalany GS; Zakaria A; Bassyouni RH
Lupus; 2012 Dec; 21(14):1565-70. PubMed ID: 22941564
[TBL] [Abstract][Full Text] [Related]
17. Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage.
Strijbos MH; Rao C; Schmitz PI; Kraan J; Lamers CH; Sleijfer S; Terstappen LW; Gratama JW
Thromb Haemost; 2008 Oct; 100(4):642-7. PubMed ID: 18841287
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum vascular cell adhesion molecule-1 and endothelin-1 levels with organ involvement and disease activity in systemic lupus erythematosus patients.
Hajialilo M; Tayari P; Ghorbanihaghjo A; Khabbazi A; Malek Mahdavi A; Rashtchizadeh N
Lupus; 2018 Oct; 27(12):1918-1925. PubMed ID: 30157717
[TBL] [Abstract][Full Text] [Related]
19. Circulating endothelial cells in patients with acute myeloid leukemia.
Wierzbowska A; Robak T; Krawczyńska A; Wrzesień-Kuś A; Pluta A; Cebula B; Smolewski P
Eur J Haematol; 2005 Dec; 75(6):492-7. PubMed ID: 16313261
[TBL] [Abstract][Full Text] [Related]
20. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.
Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H
Eur J Dermatol; 2012; 22(4):512-7. PubMed ID: 22576016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
